Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | TNFAIP3 |
| Upstream (Parents) |
|---|
| (<<) CASP1 → TNFAIP3 |
| (<<) HLA-A → TNFAIP3 |
| (<<) HLA-F → TNFAIP3 |
| (<<) HSD11B1 → TNFAIP3 |
| (<<) INPP5D → TNFAIP3 |
| (<<) JAK3 → TNFAIP3 |
| (<<) KCTD12 → TNFAIP3 |
| (<<) KIAA1949 → TNFAIP3 |
| (<<) NFAT5 → TNFAIP3 |
| (<<) PIK3CD → TNFAIP3 |
| (<<) PIK3R5 → TNFAIP3 |
| (<<) PLCG2 → TNFAIP3 |
| (<<) SH2D2A → TNFAIP3 |
| (<<) SLC20A1 → TNFAIP3 |
| (<<) SOCS1 → TNFAIP3 |
| (<<) SOCS3 → TNFAIP3 |
| (<<) SYK → TNFAIP3 |
| (<<) TRAF1 → TNFAIP3 |
| Downstream (Children) |
|---|
| TNFAIP3 → ADAM10 (>>) |
| TNFAIP3 → ADAM19 (>>) |
| TNFAIP3 → AKT3 (>>) |
| TNFAIP3 → BCL2A1 (>>) |
| TNFAIP3 → CD83 (>>) |
| TNFAIP3 → CHST2 (>>) |
| TNFAIP3 → CKB (>>) |
| TNFAIP3 → COTL1 (>>) |
| TNFAIP3 → CSNK1E (>>) |
| TNFAIP3 → CSTA (>>) |
| TNFAIP3 → CTSF (>>) |
| TNFAIP3 → CXCL2 (>>) |
| TNFAIP3 → CYP1B1 (>>) |
| TNFAIP3 → ETS1 (>>) |
| TNFAIP3 → FAS (>>) |
| TNFAIP3 → FUT4 (>>) |
| TNFAIP3 → GLI3 (>>) |
| TNFAIP3 → GNA11 (>>) |
| TNFAIP3 → ICAM1 (>>) |
| TNFAIP3 → ICAM2 (>>) |
| TNFAIP3 → KCNK1 (>>) |
| TNFAIP3 → LCP1 (>>) |
| TNFAIP3 → MMP9 (>>) |
| TNFAIP3 → NCOA7 (>>) |
| TNFAIP3 → NFKB2 (>>) |
| TNFAIP3 → NFKBIA (>>) |
| TNFAIP3 → NFKBIE (>>) |
| TNFAIP3 → PHLDA1 (>>) |
| TNFAIP3 → PODXL (>>) |
| TNFAIP3 → PRSS2 (>>) |
| TNFAIP3 → PTPRE (>>) |
| TNFAIP3 → RARB (>>) |
| TNFAIP3 → S100P (>>) |
| TNFAIP3 → SAA4 (>>) |
| TNFAIP3 → SOD2 (>>) |
| TNFAIP3 → SPSB4 (>>) |
| TNFAIP3 → STAT5A (>>) |
| TNFAIP3 → STK17B (>>) |
| TNFAIP3 → TMEM88 (>>) |
| TNFAIP3 → TNF (>>) |
| TNFAIP3 → TRAF6 (>>) |
| TNFAIP3 → TRIB3 (>>) |
| TNFAIP3 → VPS37B (>>) |
| TNFAIP3 → WNT5B (>>) |
